These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Successful treatment of pediatric stroke with recombinant tissue plasminogen activator (rt-PA): a case report and review of the literature. Cremer S; Berliner Y; Warren D; Jones AE CJEM; 2008 Nov; 10(6):575-8. PubMed ID: 19000355 [TBL] [Abstract][Full Text] [Related]
7. Alteplase and ischaemic stroke: have new reviews of old data helped? Lindley RI; Wardlaw JM; Sandercock PA Lancet Neurol; 2005 Apr; 4(4):249-53. PubMed ID: 15778104 [TBL] [Abstract][Full Text] [Related]
8. Intravenous recombinant tissue-type plasminogen activator in the extended time window and the US Food and Drug Administration: confused about the time. Wechsler LR; Jovin TG Stroke; 2012 Sep; 43(9):2517-9. PubMed ID: 22910892 [No Abstract] [Full Text] [Related]
9. Alteplase for acute stroke revisited: the first 10 years. Lyden PD; Lees KR; Davis SM Lancet Neurol; 2006 Sep; 5(9):722-4. PubMed ID: 16914399 [No Abstract] [Full Text] [Related]
10. Thrombolysis with alteplase for acute ischemic stroke: review of SITS-MOST and other Phase IV studies. Külkens S; Hacke W Expert Rev Neurother; 2007 Jul; 7(7):783-8. PubMed ID: 17610385 [TBL] [Abstract][Full Text] [Related]
11. Alteplase for stroke. American Heart Association explains how guidelines were formulated. Faxon D BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092606 [No Abstract] [Full Text] [Related]
16. Alteplase for stroke. Uncertainty remains about efficacy. Mann H BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12089100 [No Abstract] [Full Text] [Related]
17. Symptomatic ICH and outcomes in patients after IV tPA: a business of risk or risky business? Southerland AM; Malik S; Johnston KC Neurology; 2011 Jul; 77(4):315-6. PubMed ID: 21715703 [No Abstract] [Full Text] [Related]
18. Emergency physician survey: recombinant tissue plasminogen activator for stroke. Mann J Ann Emerg Med; 2006 Oct; 48(4):476; author reply 477. PubMed ID: 16997689 [No Abstract] [Full Text] [Related]
19. Stroking the data: re-analysis of the NINDS trial. Magid D; Naviaux N; Wears RL Ann Emerg Med; 2005 Apr; 45(4):385-7. PubMed ID: 15795716 [No Abstract] [Full Text] [Related]
20. Alteplase for stroke. Patients and doctors are being misled by promotional pressures. Li J; Nathanson LA; Mills TJ; Netland KE; Paula R; Ragland D BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092605 [No Abstract] [Full Text] [Related] [Next] [New Search]